Dopamine d2 Receptor anticorps (Internal Region)

N° du produit ABIN6261364

Détail du produit anti-Dopamine d2 Receptor anticorps

Antigène: Dopamine d2 Receptor (DRD2) (Dopamine Receptor D2 (DRD2))

Épitope: Internal Region

Reactivité: Humain, Rat, Souris

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp Dopamine d2 Receptor est non-conjugé

Application: Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunocytochemistry (ICC), Immunofluorescence (IF)

Specificité: DRD2 Antibody detects endogenous levels of total DRD2.

Homologie: Pig,Bovine,Horse,Sheep,Rabbit,Dog

Purification: The antiserum was purified by peptide affinity chromatography using SulfoLink^TM Coupling Resin (Thermo Fisher Scientific).

Immunogène: A synthesized peptide derived from human DRD2, corresponding to a region within the internal amino acids.

Isotype: IgG

Information d'application

Indications d'application: WB 1:1000-3000, IF/ICC 1:100-1:500, IHC 1:50-1:200, ELISA(peptide) 1:20000-1:40000

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/mL

Buffer: Rabbit IgG in phosphate buffered saline , pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20 °C. Stable for 12 months from date of receipt.

Date de péremption: 12 months

Références pour anticorps anti-Dopamine d2 Receptor (ABIN6261364)

Liu, Geng, Zhang, Wang, Zhang, Duan, Zhang: "Oligo-Porphyran Ameliorates Neurobehavioral Deficits in Parkinsonian Mice by Regulating the PI3K/Akt/Bcl-2 Pathway." dans: Marine drugs, Vol. 16, Issue 3, (2018) (PubMed).

Détails sur Dopamine d2 Receptor

Antigène: Dopamine d2 Receptor (DRD2) (Dopamine Receptor D2 (DRD2))

Autre désignation: DRD2 (DRD2 Produits)

Synonymes: anticorps D2DR, anticorps D2R, anticorps drd2b, anticorps d2r2, anticorps Drd-2, anticorps d2dr, anticorps d2r, anticorps drd2, anticorps drd2-B, anticorps DRD2, anticorps D2, anticorps CG18741, anticorps CG7569, anticorps DAMB, anticorps DDR2, anticorps DOPR2, anticorps DOPR99B, anticorps Dar2, anticorps Dmel\\CG18741, anticorps DopD1, anticorps DopR99B, anticorps DopRII, anticorps dopamine receptor D2, anticorps dopamine receptor D2 like, anticorps dopamine receptor D2 L homeolog, anticorps dopamine receptor D2 S homeolog, anticorps Dopamine 1-like receptor 2, anticorps DRD2, anticorps drd2l, anticorps drd2, anticorps Drd2, anticorps drd2.L, anticorps drd2.S, anticorps Dop1R2

Sujet:

Description: Dopamine receptor whose activity is mediated by G proteins which inhibit adenylyl cyclase.

Gene: DRD2

Poids moléculaire: 51 kDa

ID gène: 1813

UniProt: P14416

Pathways: Positive Regulation of Peptide Hormone Secretion, Negative Regulation of Hormone Secretion, cAMP Metabolic Process, Inositol Metabolic Process, Regulation of G-Protein Coupled Receptor Protein Signaling, Feeding Behaviour, Negative Regulation of Transporter Activity, Regulation of long-term Neuronal Synaptic Plasticity